Patheon is a global provider of development and commercial manufacturing services for solid and sterile prescription drugs, offering a wide variety of services and products. SEE AND Read More »

Want to learn more?

Patheon Overview Brochure

Quick to Clinic™

Accelerated Delivery of Phase I Clinical Trial Materials

Just four months, with the Quick to Clinic™ program that's how fast you can formulate a solid dose molecule into a finished drug product and get your clinical trial material for First Time in Human (Phase I) studies.

Utilizing Patheon's network of specialized facilities throughout North America and Europe, the Quick to Clinic™ program assures delivery of finished drug product within four months from receipt of API. These early-phase development centers will provide responsive and flexible service to customers who are under pressure to screen product ideas and make proof of concept decisions quickly.

Fast, flexible, proven.

  • Delivery within four months from receipt of API

Specialized early phase development centers

  • Global network
  • No scheduling competition with late phase projects

Simple, fit-for-purpose formulations

  • Blend in capsule
  • API in bottle
  • API in capsule
  • Tablet
  • Blend in bottle
  • Oral solution

Quick to Clinic enables you to start projects quickly, achieve faster clinical results, and make faster proof of concept decisions, all while minimizing the use of costly API material. With a fixed price and timeline, Quick to Clinic is the smart way to keep your project moving forward.

Case Study: Quick to Clinic™ – Release of Clinical Batches in Only Seven Weeks

The Challenge The customer came to Patheon needing 50 mg capsules of neat API for Phase 1 clinical trials.

The Solution First we validated their assay and dissolution methods. Then we manufactured a prototype batch, which we subjected to a one-month stability test to confirm the suitability of the approach. Disposable manufacturing equipment was employed to eliminate the requirement for cleaning verification.

The Outcome The clinical batches were manufactured and released in just seven weeks – including a 4-week stability test.

Ask The Experts

Anil Kane, Ph.D., MBA

Anil Kane, Ph.D., MBA
Dr. Kane has more than 25 years of experience in the science and business of taking molecules throug
Read More »

Larry Gatlin, Ph.D.

Larry Gatlin, Ph.D.
Dr. Gatlin is an industry veteran with more than 36 years of scientific and leadership experience. H
Read More »

Leah Appel, Ph.D.

Leah Appel, Ph.D.
Dr. Appel has over 20 years’ experience in the pharmaceutical industry developing drug delivery tech
Read More »

View All »

Knowledge Library

Please fill the below form to access requested content

First Name

Last Name





Address Line 1

Address Line 2


Zip/ Postal Code